These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2161449)

  • 1. Chemoembolization for hepatocellular carcinoma.
    Venook AP; Stagg RJ; Lewis BJ; Chase JL; Ring EJ; Maroney TP; Hohn DC
    J Clin Oncol; 1990 Jun; 8(6):1108-14. PubMed ID: 2161449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization in liver malignant involvement. Experiences on 17 cases.
    Fiorentini G; Campanini A; Dazzi C; Davitti B; Graziani G; Priori T; Ricci Bitti R; Angelini L
    Minerva Chir; 1994 Apr; 49(4):281-5. PubMed ID: 8072703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea.
    Ikeda M; Arai Y; Park SJ; Takeuchi Y; Anai H; Kim JK; Inaba Y; Aramaki T; Kwon SH; Yamamoto S; Okusaka T; ;
    J Vasc Interv Radiol; 2013 Apr; 24(4):490-500. PubMed ID: 23466316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Pelletier G; Roche A; Ink O; Anciaux ML; Derhy S; Rougier P; Lenoir C; Attali P; Etienne JP
    J Hepatol; 1990 Sep; 11(2):181-4. PubMed ID: 2174933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterioportal shunts in patients with hepatocellular carcinoma treated using ethanol-soaked gelatin sponge: therapeutic effects and prognostic factors.
    Zhou WZ; Shi HB; Liu S; Yang ZQ; Zhou CG; Xia JG; Zhao LB; Li LS
    J Vasc Interv Radiol; 2015 Feb; 26(2):223-30. PubMed ID: 25645411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative chemoembolization of hepatocellular carcinoma with mitoxantrone, Lipiodol, and Gelfoam. A phase II study.
    Civalleri D; Pellicci R; Decaro G; Giangaspero A; Ettorre G; Decian F; Mondini G; Simoni G
    Anticancer Res; 1996; 16(2):937-41. PubMed ID: 8687155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of hepatic artery embolization: comparison between Gelfoam and Lipiodol with anticancer agent.
    Yamashita Y; Takahashi M; Fujimura N; Kan M
    Radiat Med; 1987; 5(3):61-7. PubMed ID: 2447611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization via branches from the splenic artery in patients with hepatocellular carcinoma.
    Choi JW; Kim HC; Chung JW; Kim JD; Kim GM; Lee IJ; Jae HJ; Park JH
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):90-6. PubMed ID: 21305284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
    Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
    Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma].
    Yodono H; Tarusawa K; Kanehira J; Fukuda E; Ikami I; Sakaki T; Kamata K; Sasaki D; Sasaki M
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3476-82. PubMed ID: 3024580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoembolization therapy with lipiodol, cisplatin and etoposide for hepatocellular carcinoma].
    Inoue A; Kojima J; Kasugai H; Okuda S; Fujita M; Shibata K; Sasaki Y; Imaoka S; Ishiguro S
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2788-93. PubMed ID: 1963631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
    Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ
    J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization.
    Nakoa N; Kamino K; Miura K; Hayashi T; Ohnishi M; Takayasu Y; Miura T; Okamoto E
    AJR Am J Roentgenol; 1991 Jun; 156(6):1177-9. PubMed ID: 1851379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transarterial segmental hepatic chemo-embolization in patients with hepatocellular carcinoma].
    Nakamura H; Hashimoto T; Inoue K; Futami Y; Mizumoto S; Monden M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2540-3. PubMed ID: 2843120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Limitation of oily chemoembolization against hepatocellular carcinoma and arterioportal segmental chemoembolization].
    Nakamura H; Hashimoto T; Fujita M; Oi H; Inoue K; Mizumoto S; Sawada S; Takayasu Y; Hori S; Furui S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2849-52. PubMed ID: 2551227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter oily chemoembolization of hepatocellular carcinoma.
    Nakamura H; Hashimoto T; Oi H; Sawada S
    Radiology; 1989 Mar; 170(3 Pt 1):783-6. PubMed ID: 2536946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
    Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
    J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.